Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

ELIGIO DAVID SOLIMAN

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1134747082
CMS profile
10769784
Location
TEMECULA, CA

General Payments · PY2021–2025

$7,747.96

  • Reported across 67 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$1,902.56

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $1,590.00 2
Food and Beverage $312.56 15

By paying entity

PY2025 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $80.07 3
PY2022 $507.14 16
PY2023 $1,666.31 25
PY2024 $3,591.88 6
PY2025 $1,902.56 17

Payment records · PY2025 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2025 2021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Ascendis Pharma Endocrinology Inc $27.91 02/27/2025 Food and Beverage Undisputed 06/30/2026 1237034637 CMS
Ascensia Diabetes Care Us Inc. $34.12 07/24/2025 Food and Beverage Undisputed 06/30/2026 1225126566 CMS
Ascensia Diabetes Care Us Inc. $15.32 09/20/2025 Food and Beverage Undisputed 06/30/2026 1225126564 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.71 07/17/2025 Food and Beverage Undisputed 06/30/2026 1225814719 CMS
CeQur Corporation $19.11 06/26/2025 Food and Beverage Undisputed 06/30/2026 1228695013 CMS
Dexcom, Inc. $25.98 09/04/2025 Food and Beverage Undisputed 06/30/2026 1250553378 CMS
Insulet Corporation $30.09 04/01/2025 Food and Beverage Undisputed 06/30/2026 1207076299 CMS
Insulet Corporation $6.30 06/03/2025 Food and Beverage Undisputed 06/30/2026 1207146814 CMS
Insulet Corporation $56.28 06/11/2025 Food and Beverage Undisputed 06/30/2026 1207147903 CMS
Insulet Corporation $7.42 08/12/2025 Food and Beverage Undisputed 06/30/2026 1207106368 CMS
Insulet Corporation $39.51 08/19/2025 Food and Beverage Undisputed 06/30/2026 1207153972 CMS
Insulet Corporation $2.35 09/23/2025 Food and Beverage Undisputed 06/30/2026 1207115855 CMS
Insulet Corporation $7.78 11/10/2025 Food and Beverage Undisputed 06/30/2026 1207126345 CMS
Insulet Corporation $1.62 11/10/2025 Food and Beverage Undisputed 06/30/2026 1207161432 CMS
Novo Nordisk Inc $795.00 08/19/2025 Consulting Fee Undisputed 06/30/2026 1188513712 CMS
Novo Nordisk Inc $795.00 08/20/2025 Consulting Fee Undisputed 06/30/2026 1188618174 CMS
TOLMAR, INC. $19.06 08/21/2025 Food and Beverage Undisputed 06/30/2026 1237017057 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.